<VariationArchive VariationID="424824" VariationName="NM_000070.2(CAPN3):c.[223dupT];[439C&gt;T]" VariationType="CompoundHeterozygote" Accession="VCV000424824" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-23" DateCreated="2016-07-01" MostRecentSubmission="2016-07-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <Genotype VariationID="424824">
      <SimpleAllele AlleleID="98322" VariationID="92411">
        <GeneList>
          <Gene Symbol="CAPN3" FullName="calpain 3" GeneID="825" HGNC_ID="HGNC:1480" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>15q15.1</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="42359501" stop="42412317" display_start="42359501" display_stop="42412317" Strand="+" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="42651697" stop="42704514" display_start="42651697" display_stop="42704514" Strand="+" />
            </Location>
            <OMIM>114240</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_000070.3(CAPN3):c.223dup (p.Tyr75fs)</Name>
        <CanonicalSPDI>NC_000015.10:42360025:TTT:TTTT</CanonicalSPDI>
        <VariantType>Duplication</VariantType>
        <Location>
          <CytogeneticLocation>15q15.1</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="42360025" stop="42360026" display_start="42360025" display_stop="42360026" variantLength="1" positionVCF="42360025" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="42652223" stop="42652224" display_start="42652223" display_stop="42652224" variantLength="1" positionVCF="42652223" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        </Location>
        <ProteinChange>Y75fs</ProteinChange>
        <HGVSlist>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.42360028dup" Assembly="GRCh38">
              <Expression>NC_000015.10:g.42360028dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.42652226dup" Assembly="GRCh37">
              <Expression>NC_000015.9:g.42652226dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_008660.1" sequenceAccession="NG_008660" sequenceVersion="1" change="g.16926dup">
              <Expression>NG_008660.1:g.16926dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_000070.3" sequenceAccession="NM_000070" sequenceVersion="3" change="c.223dup" MANESelect="true">
              <Expression>NM_000070.3:c.223dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_000061.1" sequenceAccession="NP_000061" sequenceVersion="1" change="p.Tyr75fs">
              <Expression>NP_000061.1:p.Tyr75fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_024344.2" sequenceAccession="NM_024344" sequenceVersion="2" change="c.223dup">
              <Expression>NM_024344.2:c.223dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_077320.1" sequenceAccession="NP_077320" sequenceVersion="1" change="p.Tyr75fs">
              <Expression>NP_077320.1:p.Tyr75fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_173087.2" sequenceAccession="NM_173087" sequenceVersion="2" change="c.223dup">
              <Expression>NM_173087.2:c.223dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_775110.1" sequenceAccession="NP_775110" sequenceVersion="1" change="p.Tyr75fs">
              <Expression>NP_775110.1:p.Tyr75fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_849" sequenceAccession="LRG_849">
              <Expression>LRG_849:g.16926dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_849t1" sequenceAccession="LRG_849t1">
              <Expression>LRG_849t1:c.223dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_849p1" sequenceAccession="LRG_849p1" change="p.Tyr75fs">
              <Expression>LRG_849p1:p.Tyr75fs</Expression>
            </ProteinExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_000070.3" sequenceAccession="NM_000070" sequenceVersion="3" change="c.223dupT" MANESelect="true">
              <Expression>NM_000070.3:c.223dupT</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2022-07-25" DateCreated="2015-06-25" MostRecentSubmission="2024-07-14" NumberOfSubmissions="4" NumberOfSubmitters="4">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">10330340</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">15689361</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">27854218</ID>
            </Citation>
            <ConditionList>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="5780" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="3064" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2A</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2A</ElementValue>
                    <XRef ID="MONDO:0009675" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Muscular dystrophy, limb-girdle, type 2A, Amish</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Calpainopathy</ElementValue>
                    <XRef ID="NBK1313" DB="GeneReviews" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Limb-girdle muscular dystrophy type 2</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Muscular dystrophy, pelvofemoral</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Leyden-Moebius muscular dystrophy</ElementValue>
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">LGMD2</ElementValue>
                    <XRef Type="MIM" ID="253600" DB="OMIM" />
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Preferred">LGMDR1</ElementValue>
                    <XRef Type="MIM" ID="253600" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                    <XRef ID="GTR000530423" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000560317" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000511445" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000521018" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000557704" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000332444" DB="Genetic Testing Registry (GTR)" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">Calpainopathy is characterized by symmetric and progressive weakness of proximal limb-girdle muscles. The age at onset of muscle weakness ranges from two to 40 years. The phenotype shows intra- and interfamilial variability ranging from severe to mild. Three autosomal recessive calpainopathy phenotypes have been identified based on the distribution of muscle weakness and age at onset: Pelvifemoral limb-girdle muscular dystrophy (LGMD) (Leyden-Möbius LGMD) phenotype, the most frequently observed calpainopathy phenotype, in which muscle weakness is first evident in the pelvic girdle and later in the shoulder girdle, with onset that may occur as early as before age 12 years or as late as after age 30 years. Scapulohumeral LGMD (Erb LGMD) phenotype, usually a milder phenotype with infrequent early onset, in which muscle weakness is first evident in the shoulder girdle and later in the pelvic girdle. HyperCKemia, usually observed in children or young individuals, in which individuals are asymptomatic and have high serum creatine kinase (CK) concentrations. The autosomal dominant form of calpainopathy shows a variability of clinical phenotype, ranging from almost asymptomatic to wheelchair dependence after age 60 years in few cases with a generally milder phenotype than the recessive form. Clinical findings of calpainopathy include the tendency to walk on tiptoe, difficulty in running, scapular winging, waddling gait, and slight hyperlordosis. Other findings include symmetric weakness of proximal more than distal muscles in the limbs, trunk, and periscapular area; laxity of the abdominal muscles; Achilles tendon shortening; scoliosis; and joint contractures. Affected individuals typically do not have cardiac involvement or intellectual disability.</Attribute>
                    <XRef ID="NBK1313" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="1057" />
                    <XRef ID="1057" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301490</ID>
                    <ID Source="BookShelf">NBK1313</ID>
                  </Citation>
                  <XRef ID="267" DB="Orphanet" />
                  <XRef ID="C1869123" DB="MedGen" />
                  <XRef ID="MONDO:0009675" DB="MONDO" />
                  <XRef Type="MIM" ID="253600" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="44661" Type="Disease" ContributesToAggregateClassification="false">
                <Trait ID="40660" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1I</ElementValue>
                    <XRef Type="MIM" ID="618129" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Muscular dystrophy, limb-girdle, autosomal dominant 4</ElementValue>
                    <XRef ID="MONDO:0029133" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">LGMDD4</ElementValue>
                    <XRef Type="MIM" ID="618129" DB="OMIM" />
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Alternate">LGMD1I</ElementValue>
                    <XRef Type="MIM" ID="618129" DB="OMIM" />
                  </Symbol>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301490</ID>
                    <ID Source="BookShelf">NBK1313</ID>
                  </Citation>
                  <XRef ID="C4748295" DB="MedGen" />
                  <XRef ID="MONDO:0029133" DB="MONDO" />
                  <XRef Type="MIM" ID="618129" DB="OMIM" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="424824" DB="ClinVar" />
          <XRef ID="CA220346" DB="ClinGen" />
          <XRef Type="rs" ID="398123146" DB="dbSNP" />
        </XRefList>
      </SimpleAllele>
      <SimpleAllele AlleleID="226480" VariationID="242415">
        <GeneList>
          <Gene Symbol="LOC126862115" FullName="BRD4-independent group 4 enhancer GRCh37_chr15:42677734-42678933" GeneID="126862115" Source="calculated" RelationshipType="within multiple genes by overlap">
            <Location>
              <CytogeneticLocation>15q15.1</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="42385536" stop="42386735" display_start="42385536" display_stop="42386735" Strand="+" />
            </Location>
          </Gene>
          <Gene Symbol="CAPN3" FullName="calpain 3" GeneID="825" HGNC_ID="HGNC:1480" Source="submitted" RelationshipType="within multiple genes by overlap">
            <Location>
              <CytogeneticLocation>15q15.1</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="42359501" stop="42412317" display_start="42359501" display_stop="42412317" Strand="+" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="42651697" stop="42704514" display_start="42651697" display_stop="42704514" Strand="+" />
            </Location>
            <OMIM>114240</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_000070.3(CAPN3):c.439C&gt;T (p.Arg147Ter)</Name>
        <CanonicalSPDI>NC_000015.10:42386225:C:T</CanonicalSPDI>
        <VariantType>single nucleotide variant</VariantType>
        <Location>
          <CytogeneticLocation>15q15.1</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="42386226" stop="42386226" display_start="42386226" display_stop="42386226" variantLength="1" positionVCF="42386226" referenceAlleleVCF="C" alternateAlleleVCF="T" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="42678424" stop="42678424" display_start="42678424" display_stop="42678424" variantLength="1" positionVCF="42678424" referenceAlleleVCF="C" alternateAlleleVCF="T" />
        </Location>
        <ProteinChange>R147*</ProteinChange>
        <HGVSlist>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.42386226C&gt;T" Assembly="GRCh38">
              <Expression>NC_000015.10:g.42386226C&gt;T</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.42678424C&gt;T" Assembly="GRCh37">
              <Expression>NC_000015.9:g.42678424C&gt;T</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_008660.1" sequenceAccession="NG_008660" sequenceVersion="1" change="g.43124C&gt;T">
              <Expression>NG_008660.1:g.43124C&gt;T</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_000070.3" sequenceAccession="NM_000070" sequenceVersion="3" change="c.439C&gt;T" MANESelect="true">
              <Expression>NM_000070.3:c.439C&gt;T</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_000061.1" sequenceAccession="NP_000061" sequenceVersion="1" change="p.Arg147Ter">
              <Expression>NP_000061.1:p.Arg147Ter</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_024344.2" sequenceAccession="NM_024344" sequenceVersion="2" change="c.439C&gt;T">
              <Expression>NM_024344.2:c.439C&gt;T</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_077320.1" sequenceAccession="NP_077320" sequenceVersion="1" change="p.Arg147Ter">
              <Expression>NP_077320.1:p.Arg147Ter</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_173087.2" sequenceAccession="NM_173087" sequenceVersion="2" change="c.439C&gt;T">
              <Expression>NM_173087.2:c.439C&gt;T</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_775110.1" sequenceAccession="NP_775110" sequenceVersion="1" change="p.Arg147Ter">
              <Expression>NP_775110.1:p.Arg147Ter</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_849" sequenceAccession="LRG_849">
              <Expression>LRG_849:g.43124C&gt;T</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_849t1" sequenceAccession="LRG_849t1">
              <Expression>LRG_849t1:c.439C&gt;T</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_849p1" sequenceAccession="LRG_849p1" change="p.Arg147Ter">
              <Expression>LRG_849p1:p.Arg147Ter</Expression>
            </ProteinExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2024-01-28" DateCreated="2016-11-29" MostRecentSubmission="2024-06-13" NumberOfSubmissions="4" NumberOfSubmitters="4">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">10330340</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">15689361</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">17594342</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">27854218</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">30107846</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">33250842</ID>
            </Citation>
            <Citation Type="general">
              <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CAPN3</URL>
            </Citation>
            <ConditionList>
              <TraitSet ID="46902" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="3064" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Calpainopathy</ElementValue>
                    <XRef ID="NBK1313" DB="GeneReviews" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Limb-girdle muscular dystrophy type 2</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Muscular dystrophy, pelvofemoral</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Leyden-Moebius muscular dystrophy</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Muscular dystrophy, limb-girdle, type 2A, Amish</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2A</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2A</ElementValue>
                    <XRef ID="MONDO:0009675" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">LGMD2</ElementValue>
                    <XRef Type="MIM" ID="253600" DB="OMIM" />
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Preferred">LGMDR1</ElementValue>
                    <XRef Type="MIM" ID="253600" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="1057" />
                    <XRef ID="1057" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                    <XRef ID="GTR000530423" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000560317" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000511445" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000521018" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000557704" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000332444" DB="Genetic Testing Registry (GTR)" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">Calpainopathy is characterized by symmetric and progressive weakness of proximal limb-girdle muscles. The age at onset of muscle weakness ranges from two to 40 years. The phenotype shows intra- and interfamilial variability ranging from severe to mild. Three autosomal recessive calpainopathy phenotypes have been identified based on the distribution of muscle weakness and age at onset: Pelvifemoral limb-girdle muscular dystrophy (LGMD) (Leyden-Möbius LGMD) phenotype, the most frequently observed calpainopathy phenotype, in which muscle weakness is first evident in the pelvic girdle and later in the shoulder girdle, with onset that may occur as early as before age 12 years or as late as after age 30 years. Scapulohumeral LGMD (Erb LGMD) phenotype, usually a milder phenotype with infrequent early onset, in which muscle weakness is first evident in the shoulder girdle and later in the pelvic girdle. HyperCKemia, usually observed in children or young individuals, in which individuals are asymptomatic and have high serum creatine kinase (CK) concentrations. The autosomal dominant form of calpainopathy shows a variability of clinical phenotype, ranging from almost asymptomatic to wheelchair dependence after age 60 years in few cases with a generally milder phenotype than the recessive form. Clinical findings of calpainopathy include the tendency to walk on tiptoe, difficulty in running, scapular winging, waddling gait, and slight hyperlordosis. Other findings include symmetric weakness of proximal more than distal muscles in the limbs, trunk, and periscapular area; laxity of the abdominal muscles; Achilles tendon shortening; scoliosis; and joint contractures. Affected individuals typically do not have cardiac involvement or intellectual disability.</Attribute>
                    <XRef ID="NBK1313" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301490</ID>
                    <ID Source="BookShelf">NBK1313</ID>
                  </Citation>
                  <XRef ID="267" DB="Orphanet" />
                  <XRef ID="C1869123" DB="MedGen" />
                  <XRef ID="MONDO:0009675" DB="MONDO" />
                  <XRef Type="MIM" ID="253600" DB="OMIM" />
                </Trait>
                <Trait ID="40660" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1I</ElementValue>
                    <XRef Type="MIM" ID="618129" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Muscular dystrophy, limb-girdle, autosomal dominant 4</ElementValue>
                    <XRef ID="MONDO:0029133" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">LGMDD4</ElementValue>
                    <XRef Type="MIM" ID="618129" DB="OMIM" />
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Alternate">LGMD1I</ElementValue>
                    <XRef Type="MIM" ID="618129" DB="OMIM" />
                  </Symbol>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301490</ID>
                    <ID Source="BookShelf">NBK1313</ID>
                  </Citation>
                  <XRef ID="C4748295" DB="MedGen" />
                  <XRef ID="MONDO:0029133" DB="MONDO" />
                  <XRef Type="MIM" ID="618129" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="44661" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="40660" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1I</ElementValue>
                    <XRef Type="MIM" ID="618129" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Muscular dystrophy, limb-girdle, autosomal dominant 4</ElementValue>
                    <XRef ID="MONDO:0029133" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">LGMDD4</ElementValue>
                    <XRef Type="MIM" ID="618129" DB="OMIM" />
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Alternate">LGMD1I</ElementValue>
                    <XRef Type="MIM" ID="618129" DB="OMIM" />
                  </Symbol>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301490</ID>
                    <ID Source="BookShelf">NBK1313</ID>
                  </Citation>
                  <XRef ID="C4748295" DB="MedGen" />
                  <XRef ID="MONDO:0029133" DB="MONDO" />
                  <XRef Type="MIM" ID="618129" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="5780" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="3064" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Calpainopathy</ElementValue>
                    <XRef ID="NBK1313" DB="GeneReviews" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Limb-girdle muscular dystrophy type 2</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Muscular dystrophy, pelvofemoral</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Leyden-Moebius muscular dystrophy</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Muscular dystrophy, limb-girdle, type 2A, Amish</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2A</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2A</ElementValue>
                    <XRef ID="MONDO:0009675" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">LGMD2</ElementValue>
                    <XRef Type="MIM" ID="253600" DB="OMIM" />
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Preferred">LGMDR1</ElementValue>
                    <XRef Type="MIM" ID="253600" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="1057" />
                    <XRef ID="1057" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                    <XRef ID="GTR000530423" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000560317" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000511445" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000521018" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000557704" DB="Genetic Testing Registry (GTR)" />
                    <XRef ID="GTR000332444" DB="Genetic Testing Registry (GTR)" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">Calpainopathy is characterized by symmetric and progressive weakness of proximal limb-girdle muscles. The age at onset of muscle weakness ranges from two to 40 years. The phenotype shows intra- and interfamilial variability ranging from severe to mild. Three autosomal recessive calpainopathy phenotypes have been identified based on the distribution of muscle weakness and age at onset: Pelvifemoral limb-girdle muscular dystrophy (LGMD) (Leyden-Möbius LGMD) phenotype, the most frequently observed calpainopathy phenotype, in which muscle weakness is first evident in the pelvic girdle and later in the shoulder girdle, with onset that may occur as early as before age 12 years or as late as after age 30 years. Scapulohumeral LGMD (Erb LGMD) phenotype, usually a milder phenotype with infrequent early onset, in which muscle weakness is first evident in the shoulder girdle and later in the pelvic girdle. HyperCKemia, usually observed in children or young individuals, in which individuals are asymptomatic and have high serum creatine kinase (CK) concentrations. The autosomal dominant form of calpainopathy shows a variability of clinical phenotype, ranging from almost asymptomatic to wheelchair dependence after age 60 years in few cases with a generally milder phenotype than the recessive form. Clinical findings of calpainopathy include the tendency to walk on tiptoe, difficulty in running, scapular winging, waddling gait, and slight hyperlordosis. Other findings include symmetric weakness of proximal more than distal muscles in the limbs, trunk, and periscapular area; laxity of the abdominal muscles; Achilles tendon shortening; scoliosis; and joint contractures. Affected individuals typically do not have cardiac involvement or intellectual disability.</Attribute>
                    <XRef ID="NBK1313" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301490</ID>
                    <ID Source="BookShelf">NBK1313</ID>
                  </Citation>
                  <XRef ID="267" DB="Orphanet" />
                  <XRef ID="C1869123" DB="MedGen" />
                  <XRef ID="MONDO:0009675" DB="MONDO" />
                  <XRef Type="MIM" ID="253600" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef ID="CA10602399" DB="ClinGen" />
          <XRef Type="rs" ID="878854364" DB="dbSNP" />
          <XRef Type="Interpreted" ID="424824" DB="ClinVar" />
        </XRefList>
        <AlleleFrequencyList>
          <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
          <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        </AlleleFrequencyList>
      </SimpleAllele>
      <Name>NM_000070.2(CAPN3):c.[223dupT];[439C&gt;T]</Name>
      <VariationType>CompoundHeterozygote</VariationType>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression>
            <Expression>NM_000070.2:c.[223dupT];[439C&gt;T]</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </Genotype>
    <RCVList>
      <RCVAccession Title="NM_000070.2(CAPN3):c.[223dupT];[439C&gt;T] AND Autosomal recessive limb-girdle muscular dystrophy type 2A" Accession="RCV000231993" Version="3">
        <ClassifiedConditionList TraitSetID="5780">
          <ClassifiedCondition DB="MedGen" ID="C1869123">Autosomal recessive limb-girdle muscular dystrophy type 2A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-12-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2015-12-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-07-01" MostRecentSubmission="2016-07-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27854218</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5780" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3064" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Calpainopathy</ElementValue>
                <XRef ID="NBK1313" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, pelvofemoral</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leyden-Moebius muscular dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, limb-girdle, type 2A, Amish</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2A</ElementValue>
                <XRef ID="MONDO:0009675" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LGMD2</ElementValue>
                <XRef Type="MIM" ID="253600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR1</ElementValue>
                <XRef Type="MIM" ID="253600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Calpainopathy is characterized by symmetric and progressive weakness of proximal limb-girdle muscles. The age at onset of muscle weakness ranges from two to 40 years. The phenotype shows intra- and interfamilial variability ranging from severe to mild. Three autosomal recessive calpainopathy phenotypes have been identified based on the distribution of muscle weakness and age at onset: Pelvifemoral limb-girdle muscular dystrophy (LGMD) (Leyden-Möbius LGMD) phenotype, the most frequently observed calpainopathy phenotype, in which muscle weakness is first evident in the pelvic girdle and later in the shoulder girdle, with onset that may occur as early as before age 12 years or as late as after age 30 years. Scapulohumeral LGMD (Erb LGMD) phenotype, usually a milder phenotype with infrequent early onset, in which muscle weakness is first evident in the shoulder girdle and later in the pelvic girdle. HyperCKemia, usually observed in children or young individuals, in which individuals are asymptomatic and have high serum creatine kinase (CK) concentrations. The autosomal dominant form of calpainopathy shows a variability of clinical phenotype, ranging from almost asymptomatic to wheelchair dependence after age 60 years in few cases with a generally milder phenotype than the recessive form. Clinical findings of calpainopathy include the tendency to walk on tiptoe, difficulty in running, scapular winging, waddling gait, and slight hyperlordosis. Other findings include symmetric weakness of proximal more than distal muscles in the limbs, trunk, and periscapular area; laxity of the abdominal muscles; Achilles tendon shortening; scoliosis; and joint contractures. Affected individuals typically do not have cardiac involvement or intellectual disability.</Attribute>
                <XRef ID="NBK1313" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000530423" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000560317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511445" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521018" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000557704" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332444" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1057" />
                <XRef ID="1057" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301490</ID>
                <ID Source="BookShelf">NBK1313</ID>
              </Citation>
              <XRef ID="267" DB="Orphanet" />
              <XRef ID="C1869123" DB="MedGen" />
              <XRef ID="MONDO:0009675" DB="MONDO" />
              <XRef Type="MIM" ID="253600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="498807" SubmissionDate="2016-01-25" DateLastUpdated="2016-07-01" DateCreated="2016-07-01">
        <ClinVarSubmissionID localKey="4|OMIM:253600" submittedAssembly="NCBI36" />
        <ClinVarAccession Accession="SCV000265763" DateUpdated="2016-07-01" DateCreated="2016-07-01" Type="SCV" Version="3" SubmitterName="Center for Genetic Medicine Research, Children's National Medical Center" OrgID="505157" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">27854218</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Punetha et al. (J Neuromuscul Dis. 2016)</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">27854218</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>Next-gen sequencing, Sanger sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <Genotype>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="CAPN3" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NM_000070.2:c.223dup</Attribute>
            </AttributeSet>
            <AttributeSet>
              <Attribute Type="HGVS">NM_000070.2:c.223dup</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="CAPN3" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NM_000070.2:c.439C&gt;T</Attribute>
            </AttributeSet>
            <AttributeSet>
              <Attribute Type="HGVS">NM_000070.2:c.439C&gt;T</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <VariationType>CompoundHeterozygote</VariationType>
        </Genotype>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253600" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">27854218</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27854218</ID>
        </Citation>
        <StudyDescription>Targeted sequencing using a panel of 45 myopathy related genes for 94 undiagnosed muscle disease patients.</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>targetedseq_45genepanel</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="498807" TraitType="Disease" MappingType="XRef" MappingValue="253600" MappingRef="OMIM">
        <MedGen CUI="C1869123" Name="Autosomal recessive limb-girdle muscular dystrophy type 2A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

